SCHEMBL678228

SCHEMBL678228

CC(c1ccc(N)cc1)[Sb](C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
ACHE P22303 1/20 0.38
ALDH1A1 P00352 12/20 0.36
TDP1 Q9NUW8 7/20 0.36
CYP3A4 P08684 5/20 0.36
TSHR P16473 1/20 0.36
HTT P42858 2/20 0.35
HIF1A Q16665 2/20 0.35
GAA P10253 1/20 0.35
ALOX12 P18054 1/20 0.35
TP53 P04637 3/20 0.35
TEAD4 Q15561 1/20 0.34
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
POLB P06746 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MAPK1 P28482 4/20 0.33
ALOX15 P16050 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20448417 0.87 ESR1 (0.35)
SCHEMBL5955 0.75 MAPT (0.53) MAPTMEN1KMT2AACHEALDH1A1
SCHEMBL2145868 0.75 ADRB2 (0.52) TDP1TSHRHIF1ATP53MAPK1
SCHEMBL678288 0.75 ESR1 (0.56) MAPTMEN1KMT2AALDH1A1TDP1
SCHEMBL677313 0.74 TAAR1 (0.42) ALDH1A1TSHRHIF1AKDM4E
SCHEMBL3482829 0.73 ESR1 (0.52) MAPTMEN1KMT2AACHEALDH1A1
SCHEMBL8095943 0.73 ESR1 (0.52) MAPTMEN1KMT2AACHEALDH1A1
SCHEMBL8164161 0.73 ESR1 (0.52) MAPTMEN1KMT2AACHEALDH1A1
SCHEMBL7518483 0.73 MEN1 (0.50) MAPTMEN1KMT2AACHEALDH1A1
Water SCHEMBL4672027 0.73 MAPT (0.50) MAPTMEN1KMT2AACHEALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110275774-A1 ORGANOANTIMONY COMPOUND, PROCESS FOR PREPARING SAME, LIVING RADICAL POLYMERIZATION INITIATOR, PROCESS FOR PRODUCING POLYMER WITH USE OF SAME, AND THE POLYMER YAMAGO SHIGERU 2011-11-10 US disclosed
US-8008414-B2 Organic antimony compound, process for producing the same, living radical polymerization initiator, process for producing polymer using the same, and polymer OTSUKA CHEMICAL CO., LTD. (JP) 2011-08-30 US disclosed
EP-1767539-B1 ORGANIC ANTIMONY COMPOUND, PROCESS FOR PRODUCING THE SAME, LIVING RADICAL POLYMERIZATION INITIATOR, PROCESS FOR PRODUCING POLYMER USING THE SAME, AND POLYMER OTSUKA CHEMICAL CO LTD (JP) 2011-07-27 EP disclosed
US-20090299008-A1 Organic antimony compound, process for producing the same, living radical polymerization initiator, process for producing polymer using the same, and polymer OTSUKA CHEMICAL CO., LTD. (JP) 2009-12-03 US disclosed
EP-1767539-A1 ORGANIC ANTIMONY COMPOUND, PROCESS FOR PRODUCING THE SAME, LIVING RADICAL POLYMERIZATION INITIATOR, PROCESS FOR PRODUCING POLYMER USING THE SAME, AND POLYMER OTSUKA CHEMICAL COMPANY, LTD. (JP) 2007-03-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090299008-A1 Organic antimony compound, process for producing the same, living radical polymerization initiator, process for producing polymer using the same, and polymer AOC2, ODC1, MCM7 MAPT 2424/4885MEN1 247/4885KMT2A 1071/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.